7-95308106-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_000446.7(PON1):c.603G>A(p.Ala201Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,614,086 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00087 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 2 hom. )
Consequence
PON1
NM_000446.7 synonymous
NM_000446.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.10
Publications
6 publications found
Genes affected
PON1 (HGNC:9204): (paraoxonase 1) This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017]
PON1 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 7-95308106-C-T is Benign according to our data. Variant chr7-95308106-C-T is described in ClinVar as [Benign]. Clinvar id is 715878.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-6.1 with no splicing effect.
BS2
High AC in GnomAd4 at 132 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PON1 | ENST00000222381.8 | c.603G>A | p.Ala201Ala | synonymous_variant | Exon 6 of 9 | 1 | NM_000446.7 | ENSP00000222381.3 | ||
PON1 | ENST00000433729.1 | n.*328G>A | non_coding_transcript_exon_variant | Exon 6 of 9 | 3 | ENSP00000407359.1 | ||||
PON1 | ENST00000433729.1 | n.*328G>A | 3_prime_UTR_variant | Exon 6 of 9 | 3 | ENSP00000407359.1 |
Frequencies
GnomAD3 genomes AF: 0.000868 AC: 132AN: 152138Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
132
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00111 AC: 278AN: 251376 AF XY: 0.00113 show subpopulations
GnomAD2 exomes
AF:
AC:
278
AN:
251376
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00158 AC: 2315AN: 1461830Hom.: 2 Cov.: 31 AF XY: 0.00157 AC XY: 1144AN XY: 727224 show subpopulations
GnomAD4 exome
AF:
AC:
2315
AN:
1461830
Hom.:
Cov.:
31
AF XY:
AC XY:
1144
AN XY:
727224
show subpopulations
African (AFR)
AF:
AC:
12
AN:
33476
American (AMR)
AF:
AC:
24
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26132
East Asian (EAS)
AF:
AC:
1
AN:
39688
South Asian (SAS)
AF:
AC:
37
AN:
86254
European-Finnish (FIN)
AF:
AC:
45
AN:
53416
Middle Eastern (MID)
AF:
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2079
AN:
1111978
Other (OTH)
AF:
AC:
113
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
127
254
382
509
636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000867 AC: 132AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000820 AC XY: 61AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
132
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
61
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
12
AN:
41564
American (AMR)
AF:
AC:
7
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
3
AN:
4822
European-Finnish (FIN)
AF:
AC:
7
AN:
10594
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
102
AN:
68008
Other (OTH)
AF:
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 08, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.